Expression of the proto-oncogenes survivin (BIRC5), epidermal growth factor (ERBB-2/HER2-NEU), GLI, vascular endothelial growth factor (VEGF) and the anti-oncogene TR53 in the tissues of experimental animals in toxoplasmosis

MLA

E. S. Pashinskaya. “Expression of the Proto-Oncogenes Survivin (BIRC5), Epidermal Growth Factor (ERBB-2/HER2-NEU), GLI, Vascular Endothelial Growth Factor (VEGF) and the Anti-Oncogene TR53 in the Tissues of Experimental Animals in Toxoplasmosis.” Ukrainian Journal of Occupational Health, vol. 2021, June 2021, pp. 116–27. EBSCOhost, https://doi.org/10.33573/ujoh2021.02.116.

APA

E. S. Pashinskaya. (2021). Expression of the proto-oncogenes survivin (BIRC5), epidermal growth factor (ERBB-2/HER2-NEU), GLI, vascular endothelial growth factor (VEGF) and the anti-oncogene TR53 in the tissues of experimental animals in toxoplasmosis. Ukrainian Journal of Occupational Health, 2021, 116–127. https://doi.org/10.33573/ujoh2021.02.116

Chicago

E. S. Pashinskaya. 2021. “Expression of the Proto-Oncogenes Survivin (BIRC5), Epidermal Growth Factor (ERBB-2/HER2-NEU), GLI, Vascular Endothelial Growth Factor (VEGF) and the Anti-Oncogene TR53 in the Tissues of Experimental Animals in Toxoplasmosis.” Ukrainian Journal of Occupational Health 2021 (June): 116–27. doi:10.33573/ujoh2021.02.116.